CJC-1295 DAC: research reference

Distinguish local mechanism from integrated effect. A whole-axis result needs its time context and cannot be summarized by a receptor name.

The affinity group forms a covalent bond with serum albumin in in vitro studies, modifying the peptide's exposure profile. The molecular target remains the GHRH receptor, which is coupled to Gs protein.

The purity value is a product-label specification, not an assay result. A batch result can only be asserted from that batch’s certificate.

These names help identify the catalog entry. A descriptive label is not evidence of efficacy, and structural identity still requires appropriate documentation.

GHRH analog

Reconstitution: Laboratory procedure: allow the closed vial to reach room temperature, disinfect the septum and slowly transfer the diluent against the inner wall of the vial. Do not shake; gently swirl the vial until fully dissolved. Record the volume, diluent and date in the batch log.

Storage: Sealed vial of lyophilized material: store at −20 °C, protected from light and moisture. Avoid repeated freeze-thaw cycles of reconstituted material; aliquot when the experimental design permits.

Personal protective equipment: Handle in a clean work area with a lab coat, nitrile gloves and eye protection. Dispose of vials, tips and sharps according to the laboratory waste procedure.

Teichman and colleagues examined the long-acting analog in healthy adults in two masked, placebo-controlled studies, measuring GH and IGF-I concentrations and compound-exposure parameters. These are endocrine variables, not an evaluation of athletic performance or present-day commercial products. Sources: PMID 16352683.

The cited study observed sustained GH and IGF-I changes and cumulative behavior after repeated exposure. Compound presence and measured hormonal response must be distinguished. Their different curves cannot be collapsed into one universal duration. Sources: PMID 16352683.

Ionescu and Frohman used serial nighttime GH sampling before and after exposure to the long-acting analog. Pulsatility was preserved and baseline concentrations between pulses increased. Pulse frequency and magnitude did not show the same change. Mean concentration alone does not capture all these features. Sources: PMID 17018654.

The pulsatility paper explicitly identifies an analog that binds endogenous albumin. That is part of its experimental identity. Similar commercial names do not transfer the study’s temporal observations to a No-DAC preparation. Sources: PMID 17018654.

The observations belong to the cited studies’ populations, materials and follow-up periods. Reading them does not certify a Asciende batch’s identity or quality. Comparison requires separating the compound paper, technical specification and batch-specific certificate. Sources: PMID 16352683; PMID 17018654.